1.Hung T-H, Skepper JN, Charnock-Jones DS, et al. Hypoxia-reoxygenation: a potent inducer of apoptotic changes in the human placenta and possible etiological factor in preeclampsia. Circulation research. 2002;90(12):1274–1281.
2.Soleymanlou N, Jurisica I, Nevo O, et al. Molecular evidence of placental hypoxia in preeclampsia. The Journal of Clinical Endocrinology & Metabolism. 2005;90(7):4299–4308.
3.Turpin CA, Sakyi SA, Owiredu WK, et al. Association between adverse pregnancy outcome and imbalance in angiogenic regulators and oxidative stress biomarkers in gestational hypertension and preeclampsia. BMC pregnancy and childbirth. 2015;15(1):189.
4.Kim S-Y, Ryu H-M, Yang J-H, et al. Increased sFlt–1 to PlGF ratio in women who subsequently develop preeclampsia. Journal of Korean medical science. 2007;22(5):873–877.
5.Osungbade KO, Ige OK. Public health perspectives of preeclampsia in developing countries: implication for health system strengthening. Journal of pregnancy. 2011;2011.
6.Wilkinson J, Cole G. Preeclampsia knowledge among women in Utah. Hypertension in pregnancy. 2018;37(1):18–24.
7.Raymond D, Peterson E. A critical review of early-onset and late-onset preeclampsia. Obstetrical & gynecological survey. 2011;66(8):497–506.
8.Portelli M, Baron B. Clinical presentation of preeclampsia and the diagnostic value of proteins and their methylation products as biomarkers in pregnant women with preeclampsia and their newborns. Journal of pregnancy. 2018;2018.
9.Group NHBPEPW. Report of the National High Blood Pressure Education Working Group on high blood pressure in pregnancy. Am J Obstet Gynecol. 2000;183:1–22.
10.Gabbe SG, Niebyl JR, Simpson JL, et al. Obstetrics: Normal and Problem Pregnancies E-Book. Elsevier Health Sciences; 2016.
11.Dekker G, Sibai B. Primary, secondary, and tertiary prevention of pre-eclampsia. The Lancet. 2001;357(9251):209–215.
12.Duckitt K, Harrington D. Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies. Bmj. 2005;330(7491):565.
13.Ahenkorah L. Metabolic syndrome, oxidative stress and putative risk factors amongst ghanaian women presenting with pregnancy-induced hypertension 2009.
14.Owiredu W, Ahenkorah L, Turpin C, et al. Putative risk factors of pregnancy-induced hypertension among Ghanaian pregnant women. Journal of Medical and Biomedical Sciences. 2012;1(3):62–76.
15.Nakimuli A, Chazara O, Byamugisha J, et al. Pregnancy, parturition and preeclampsia in women of African ancestry. American journal of obstetrics and gynecology. 2014;210(6):510–520. e1.
16.Vata PK, Chauhan NM, Nallathambi A, et al. Assessment of prevalence of preeclampsia from Dilla region of Ethiopia. BMC research notes. 2015;8(1):816.
17.Obed S, Patience A. Birth Weight and Ponderal Index in Pre-Eclampsia: A Comparative Study. Ghana Medical Journal. 2006:8–13.
18.Pauli JM, Repke JT. Preeclampsia: short-term and long-term implications. Obstetrics and Gynecology Clinics. 2015;42(2):299–313.
19.Tooher J, Thornton C, Makris A, et al. All hypertensive disorders of pregnancy increase the risk of future cardiovascular disease. Hypertension. 2017;70(4):798–803.
20.Murphy MS, Smith GN. Pre-eclampsia and cardiovascular disease risk assessment in women. American journal of perinatology. 2016;33(08):723–731.
21.Wallis AB, Tsigas EZ, Saftlas AF, et al. Prenatal education is an opportunity for improved outcomes in hypertensive disorders of pregnancy: results from an Internet-based survey. The Journal of Maternal-Fetal & Neonatal Medicine. 2013;26(16):1565–1567.
22.Adams RJ. Improving health outcomes with better patient understanding and education. Risk management and healthcare policy. 2010;3:61.
23.Howell D, Harth T, Brown J, et al. Self-management education interventions for patients with cancer: a systematic review. Supportive Care in Cancer. 2017;25(4):1323–1355.
24.You WB, Wolf M, Bailey SC, et al. Factors associated with patient understanding of preeclampsia. Hypertension in pregnancy. 2012;31(3):341–349.
25.Savage AR, Hoho L. Knowledge of pre-eclampsia in women living in Makole Ward, Dodoma, Tanzania. African health sciences. 2016;16(2):412–419.
26.Eze ED, Barasa A, Adams MD, et al. Determination, knowledge and prevalence of pregnancy-induced hypertension/eclampsia among women of childbearing age at Same District Hospital in Tanzania. International Journal of Medicine and Medical Sciences. 2018;10(2):19–26.
27.Teng SP, Keng SL. Knowledge of preeclampsia among antenatal women in a tertiary referral teaching hospital. The Malaysian Journal of Nursing. 2016;7:8–13.
28.MacGillivray I, McCaw‐Binns A, Ashley D, et al. Strategies to prevent eclampsia in a developing country: II. Use of a maternal pictorial card. International Journal of Gynecology & Obstetrics. 2004;87(3):295–300.
29.Tsigas E, Magee LA. Advocacy organisations as partners in pre-eclampsia progress: patient involvement improves outcomes. Best Practice & Research Clinical Obstetrics & Gynaecology. 2011;25(4):523–536.
30.Ogunyemi D, Benae J-L, Ukatu C. Is eclampsia preventable? A case control review of consecutive cases from an urban underserved region. Southern medical journal. 2004;97(5):440–446.
31.McConnell D, Mayes R, Llewellyn G. Women with intellectual disability at risk of adverse pregnancy and birth outcomes. Journal of Intellectual Disability Research. 2008;52(6):529–535.
32.Owolabi A, Fatusi A, Kuti O, et al. Maternal complications and perinatal outcomes in booked and unbooked Nigerian mothers. Singapore medical journal. 2008;49(7):526.